A study released Friday found that kid-size doses of Pfizer’s Covid vaccine are nearly 91 percent effective at preventing symptomatic infections in 5- to 11-year-olds.
Related Articles
-
FDA approves first drug for Covid-19: remdesivir
The Food and Drug Administration approved remdesivir to treat Covid-19 on Thursday, making it the first and only drug...
-
New Orleans businesses brace for Mardi Gras shutdown
Some bars in New Orleans have replaced the festive Mardi Gras flags that hang from their businesses at this...
-
India’s coronavirus death toll passes 100,000 as cases continue to rise
India’s death toll from the novel coronavirus surpassed 100,000 on Saturday, only the third country in the world to...
-
Surgeon general to Matthew McConaughey: Covid ‘not harmless’ in kids
The actor Matthew McConaughey revealed Tuesday that he opposes vaccine mandates for kids, prompting the U.S. surgeon general to...
-
Brazilians flock to the beach despite surge in Covid cases
IE 11 is not supported. For an optimal experience visit our site on another browser. 01:13 Share this –...
-
Britain cut adrift as mutant virus strain prompts global alarm
LONDON — The United Kingdom found itself increasingly cut adrift from the outside world Monday as countries took drastic...
-
Judge says hospital cannot be forced to administer ivermectin, reversing earlier decision
A judge ruled Monday that an Ohio hospital cannot be forced to give a patient ivermectin for Covid-19, reversing...
-
Russia’s Sputnik V Covid vaccine appears effective, study finds
MOSCOW — Russian scientists say the country’s Sputnik V vaccine appears safe and effective against Covid-19, according to early...
Recent Comments